Test - Physician's Channel - Mount Sinai New York

Skip to main content

Extraordinary advances are happening at the Mount Sinai Health System, and we want you to be among the first to know. Mount Sinai Physician’s Channel will show you some of the innovative procedures, developments in patient care, and complex cases that are being handled in our world-class facilities. We invite you to come back often to stay on top of what’s new in your specific field.

Refer a Patient Online

Or call 212-241-4983

Featured Items

New Content

Linking Satellite and Medical Record Data to Study Climate and Lung Health

Linking Satellite and Medical Record Data to Study Climate and Lung Health

Through two innovative research projects that weave highly detailed satellite data on temperature, humidity, and air pollution together with patient medical records and hospital admission data to better understand the relationship between ...

The New Program Helping Osteoporosis Patients at Mount Sinai

The New Program Helping Osteoporosis Patients at Mount Sinai

In 2025, Mount Sinai launched a new program in partnership with the American Orthopaedic Association that will help osteoporosis patients get the care they need. The program, Own the Bone®, evaluates all patients aged 50 and older who ...

New Steven S. Elbaum Family Center for Caregiving Will Recognize and Support Caregivers

New Steven S. Elbaum Family Center for Caregiving Will Recognize and Support Caregivers

The new Steven S. Elbaum Family Center for Caregiving is a groundbreaking initiative designed to improve how America's health care system recognizes and supports caregivers.

A Gastroenterologist Knows No Limits in Growing His Professional World

A Gastroenterologist Knows No Limits in Growing His Professional World

Brijen Shah, MD who became a board member of the American Gastroenterological Association (AGA) in June 2025, is truly a doctor without borders. His career has played out at the intersection of gastroenterology with geriatrics, medical ...

Researchers Stress Need for Data Disaggregation to Unmask Cancer Disparities Among Asians

Researchers Stress Need for Data Disaggregation to Unmask Cancer Disparities Among Asians

Mount Sinai researchers are working to understand disparities among different populations of Asian Americans to overcome an important shortcoming of pan-ethnic screening programs in the United States that ignore the prevalence of gastrointestinal ...

Helping Gastroenterologists Navigate the Challenging New World of AI

Helping Gastroenterologists Navigate the Challenging New World of AI

A Mount Sinai researcher is leading efforts to apply artificial intelligence to gastroenterology, focusing on improving cancer screening through extracting and structuring information in the electronic health record.

GLP-1 Medications: Reimagining the Treatment Paradigm for Severe Crohn’s Disease

GLP-1 Medications: Reimagining the Treatment Paradigm for Severe Crohn’s Disease

Glucagon-like peptide-1 (GLP-1) agonists, the increasingly popular class of drugs for treating diabetes and obesity, may have a role to play in promoting gut healing in patients with Crohn's disease, Mount Sinai researchers believe.

Researchers Identify Molecular Glues That Protect Beta Cells From Glucolipotoxicity

Researchers Identify Molecular Glues That Protect Beta Cells From Glucolipotoxicity

The findings, by a Mount Sinai team in collaboration with European researchers, suggest a new strategy for preserving beta cell function in diabetes.

Persistent Cardiovascular and Pulmonary Abnormalities Found in PET/MRI Imaging in Long COVID Patients

Persistent Cardiovascular and Pulmonary Abnormalities Found in PET/MRI Imaging in Long COVID Patients

The study, the largest of its kind, found that patients with long COVID may exhibit inflammation in the heart and lungs for up to a year after SARS-CoV-2 infection.

Specialty Reports June 2025

Specialty Reports June 2025

Mount Sinai Health System is pleased to present these reports covering our groundbreaking research, education, and compassionate, equitable, and safe patient care.

New Science Cardiovascular Supplement + Podcast with Mount Sinai Drs. Bhatt and Swirski

New Science Cardiovascular Supplement + Podcast with Mount Sinai Drs. Bhatt and Swirski

Cardiovascular disease remains a dominant global health burden, rooted in complex molecular and cellular pathobiology that evolves across an individual’s lifespan. Yet advances at the intersection of biomedical research and technology ...

Mount Sinai and Cancer Research Institute Team Up to Improve Patient Outcomes in Immunotherapy

Mount Sinai and Cancer Research Institute Team Up to Improve Patient Outcomes in Immunotherapy

New partnership aims to deepen understanding of immune response in cancer treatment

Uncovering the Roots of Alzheimer’s Disease

Uncovering the Roots of Alzheimer’s Disease

Department of Genetics and Genomic Sciences at Mount Sinai researchers are uncovering how microglia—immune cells in the brain—contribute to Alzheimer’s disease. Led by Alison Goate, DPhil, the team identified genes and regulators tied ...

SGLT2 Inhibitor Empagliflozin Treatment Stabilizes Kidney Function in Patients Who Have Had a Heart Attack

SGLT2 Inhibitor Empagliflozin Treatment Stabilizes Kidney Function in Patients Who Have Had a Heart Attack

Mount Sinai-led study demonstrates kidney benefits of drug used in diabetes and heart failure

Precision in Practice: Shaping the Future of Individualized Care

Precision in Practice: Shaping the Future of Individualized Care

Mount Sinai researchers are advancing precision medicine by developing patient-specific tumor models, AI-driven drug repurposing pipelines, and interactive tools to improve diagnostics, treatment prediction, and therapeutic discovery across diverse diseases.

Advancing Precision Therapies for Rare Metabolic Disorders

Advancing Precision Therapies for Rare Metabolic Disorders

Eva Morava, MD, PhD, and Tamas Kozicz, MD, PhD, are advancing therapies for rare metabolic disorders using organoid models and clinical trials—bringing personalized treatments to patients with congenital disorders of glycosylation and mitochondrial diseases.

From Genome to Diagnosis: Finding Answers for the Undiagnosed

From Genome to Diagnosis: Finding Answers for the Undiagnosed

The Turro Lab is uncovering the genetic roots of rare and undiagnosed diseases using advanced genome sequencing and statistical methods—offering long-sought answers to families and driving the discovery of new genetic syndromes that impact ...

Connecting Genomes and Microbes to Unlock New Therapies

Connecting Genomes and Microbes to Unlock New Therapies

The Center for AI-Driven Genomic and Microbiome Medicine unites genomic and microbiome research to advance precision medicine—using tools like long-read sequencing and strain-level analysis to uncover how these systems interact and influence ...